Article Information
History
- January 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicholas W Fischer1,*,
- Brianne Laverty1,2,
- Noa Alon1,
- Emilie Montellier3,
- Kara N Maxwell4,5,
- Christian P Kratz6,
- Pierre Hainaut3,
- Ran Kafri7,8 and
- David Malkin1,2,10,11
- 1Program in Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Canada
- 2Department of Medical Biophysics, University of Toronto, Toronto, Canada
- 3Institute for Advanced Biosciences, Université Grenoble Alpes, Grenoble, France
- 4Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
- 5Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
- 6Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
- 7Department of Molecular Genetics, University of Toronto, Toronto, Canada
- 8Program in Cell Biology, The Hospital for Sick Children, Toronto, Canada
- 10Division of Hematology-Oncology, The Hospital for Sick Children, Toronto, Canada
- 11Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada
- ↵* Corresponding author; email: nick.fischer{at}mail.utoronto.ca
Posted January 07, 2024.
TP53 Variant Clusters Stratify the Li-Fraumeni Spectrum and Reveal an Osteosarcoma-Prone Subgroup
